Immunotherapy for Infectious Diseases

112 Kundu-Raychaudhuri and Engleman
III/LAV infection. J Invest Dermatol 1987; 88:233–237.
39. Macatonia SE, Gompels M, Pinching AJ, Patterson S, Knight S. Antigen presentation by
macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection.
Immunology 1992; 75:576–581.
40. Knight SC, Macatonia SE, Patterson S. HIV-1 infection of dendritic cells. Int Rev Immunol
1990; 6:163–175.
41. Stingl G, Rappersberger K, Tschachler E, et al. Langerhans’ cells and HIV-1 infection. J
Am Acad Dermatol 1990; 22:1210–1217.
42. Meyaard L, Schnitermaken H, Miedema F. T cell dysfunction in HIV infection: anergy
due to defective antigen-presenting cell function? Immunol Today 1993; 14:161–164.
43. Helbert MR, Stehr J-L Mitchison NA. Antigen presentation, loss of immunological memory
and AIDS. Immunol Today 1993; 14:340–344.
44. Blauvelt A, Clerici M, Lucey DR, et al. Functional studies of epidermal Langerhans cells
and blood monocytes in HIV-infected person. J Immunol 1995; 154:3506–3515.
45. Macatonia SE, Patterson S, Knight SC. Suppression of immune responses by dendritic
cells infected with HIV. Immunology 1989; 67:285–289.
46. Kundu SK, Engleman E, Benike C, et al. A pilot clinical trial of HIV antigen-pulsed allogeneic
and autologous dendritic cell therapy in HIV-infected patients. AIDS Res Hum
Retroviruses 1998; 14:551.
47. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency
virus infection. N Engl J Med 1993; 328:327–335.
48. Deng H-K, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates
of HIV-1. Nature 1996; 381:661–666.
49. Dragic T, Litwin V, Allaway GP. HIV-1 entry into CD4� cells is mediated by the
chemokine receptor CC-CKR-5. Nature 1996; 381:667–673.
50. Abrahamsohn IA, Coffman RL. Trypanosoma cruzi: IL-10, TNF, IFN-�, and IL-12 regulate
innate and acquired immunity to infection. Exp Parasitol 1996; 84:231–244.
51. Van Overtvelt L, Vanderheyde N, Verhasselt V, et al. Trypanosoma cruzi infects human
dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and
costimulatory molecules. Infect Immun 1999; 67:4033–4040.
52. von Stebut E, Belkaid Y, Jakob T, Sacks DL, Udey MC. Uptake of Leishmania major
amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic
cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 1998;
188:1547–1552.
53. Seguin R, Kasper LH. Sensitized lymphocytes and CD40 ligation augment interleukin-12
production by human dendritic cells in response to Toxoplasma gondii. J Infect Dis 1999;
179:467–474.
54. Klagge IM, Schneider-Schaulies S. Virus interactions with dendritic cells. J Gen Virol
1999; 80:823–833.
55. Redpath S, Angulo A, Gascoigne NRJ, Ghazal P. Murine cytomegalovirus infection downregulates
MHC class II expression on macrophages by induction of IL-10. J Immunol
1999; 162:6701–6707.
56. Frazer IH, Thomas R, Zhou J, et al. Potential strategies utilised by papillomavirus to evade
host immunity. Immunol Rev 1999; 168:131–142.
57. West SK, Rapoza P, Munoz B, Katala S, Taylor HR. Epidemiology of ocular chlamydial
infection in a trachoma-hyperendemic area. J Infect Dis 1991; 163:752–756.
58. Bavoil PM, Hsia RC, Rank RG. Prospects for a vaccine against chlamydia genital disease.
I. Microbiology and pathogenesis. Bull Inst Pasteur 1996; 94:5.
59. Su H, Caldwell HD. CD4� T cells play a significant role in adoptive immunity to Chlamydia
trachomatis infection of the mouse genital tract. Infect Immun 1995; 63:3302–3308.
60. Zhang D, Yang X, Lu H, Zhong G, Brunham RC. Immunity to Chlamydia trachomatis